4th Targeted Radiopharmaceuticals Summit 2025

 

With over 400 active radiopharmaceuticals in development and expanding into new disease indications, the 4th Targeted Radiopharmaceuticals Summit US returns to San Diego as the largest industry-focused platform. Bringing together over 275 global stakeholders, the summit will showcase exclusive scientific and strategic insights from major players like Novartis, AstraZeneca, BMS, Ratio Therapeutics, Alpha-9 Oncology, AdvanCell, Mariana Oncology, Abdera Therapeutics, and more.

The refreshed program will cover the latest industry advancements and address key challenges. Focused on industry-specific topics, the summit aims to advance approvals and commercialization, with an emphasis on isotope supply, clinical development, regulatory clarity, and novel molecule design.

Read more to view the official program here…

More Info

Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy